Vaxxinity, Inc. Class A Common Stock
VAXX
VAXX was delisted on the 8th of May, 2024.
52 hedge funds and large institutions have $16.4M invested in Vaxxinity, Inc. Class A Common Stock in 2023 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 13 increasing their positions, 12 reducing their positions, and 5 closing their positions.
60% more first-time investments, than exits
New positions opened: 8 | Existing positions closed: 5
6% more funds holding
Funds holding: 49 → 52 (+3)
8% more repeat investments, than reductions
Existing positions increased: 13 | Existing positions reduced: 12
45% less capital invested
Capital invested by funds: $29.5M → $16.4M (-$13.1M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$336K |
| 2 |
State Street
Boston,
Massachusetts
|
+$123K |
| 3 |
Geode Capital Management
Boston,
Massachusetts
|
+$97.7K |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$61.7K |
| 5 |
ML
McAdam LLC
Philadelphia,
Pennsylvania
|
+$47.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VOYA Investment Management
Atlanta,
Georgia
|
-$47.2K |
| 2 |
Bank of New York Mellon
New York
|
-$45.9K |
| 3 |
New York State Common Retirement Fund
Albany,
New York
|
-$44.3K |
| 4 |
Millennium Management
New York
|
-$35.3K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$33.8K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
EBA
51
Eagle Bay Advisors
New York
| $44 | +$69 | +32 | New |
|
52
Citigroup
New York
| $30 | -$27.5K | -12,671 | -100% |
|
|
53
VOYA Investment Management
Atlanta,
Georgia
| – | -$47.2K | -18,742 | Closed |
|
|
54
Millennium Management
New York
| – | -$35.3K | -14,012 | Closed |
|
55
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$31.3K | -12,411 | Closed |
|
|
SWM
56
Spire Wealth Management
Mclean,
Virginia
| – | -$3.78K | -1,500 | Closed |
|
|
VWM
57
Venturi Wealth Management
Austin,
Texas
| – | -$114 | -45 | Closed |
|
VAXX Hedge Fund Activity: Q3 2023 in Review
52 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Vaxxinity, Inc. Class A Common Stock (VAXX) for Q3 2023, worth a combined $16.4M — down 45% from $29.5M a quarter earlier.
Buyers outnumbered sellers: 8 funds opened new VAXX positions and 5 closed out — a net gain of 3 holders — while 13 added to existing stakes and 12 trimmed.
The largest buyer was BlackRock, adding an estimated $336K. The largest seller was VOYA Investment Management, exiting entirely with an estimated $47.2K sold.
- 52 institutional investors held Vaxxinity, Inc. Class A Common Stock (VAXX) as of Q3 2023, up from 49 in Q2 2023.
- Funds reported $16.4M of Vaxxinity, Inc. Class A Common Stock stock for Q3 2023, down 45% quarter-over-quarter.
- 8 funds opened new Vaxxinity, Inc. Class A Common Stock positions in Q3 2023 and 5 closed out, a net change of +3 holders.
- The largest Vaxxinity, Inc. Class A Common Stock buyer in Q3 2023 was BlackRock, an estimated $336K added.
- The largest Vaxxinity, Inc. Class A Common Stock seller in Q3 2023 was VOYA Investment Management, an estimated $47.2K sold.
Based on aggregated 13F filings for Q3 2023.